Compare iShares MSCI Indonesia ETF (EIDO) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs F5 Inc — how do they compare? iShares MSCI Indonesia ETF trades at $11.91 (market cap $409.22M), while F5 Inc trades at $480.03 (market cap $26.14B). The key difference: F5 Inc is far larger — about 63.9× iShares MSCI Indonesia ETF's market cap, and F5 Inc is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Indonesia ETF for 76 Days and F5 Inc for 38 Days on average.
| EIDO | FFIV | |
|---|---|---|
Market Cap | $409.22M | $26.14B |
Volume | 879,527 | 503,146 |
52-Week High | $19.22 | $469.79 |
52-Week Low | $10.80 | $223.99 |
Typical Hold Time | 76 Days | 38 Days |
Sector | — | Technology |
Enterprise Value | — | $24.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EIDO trades at $11.87, showing minimal daily movement with a 0.08% gain. Technical indicators signal a bearish trend, with moving averages and ADX pointing downward, though RSI levels hint at potential oversold conditions. Recent news highlights underperformance amid sector rotation away from Asian equities, with volume declining 21% below average. Key financial ratios are unavailable in the provided data, limiting fundamental assessment.
The outlook remains cautious due to weak price action and bearish technicals. Risks include high financials exposure and slow EPS growth. Upside may depend on seasonal trends or valuation support, but current sentiment and institutional flows suggest continued pressure. Investors should weigh technical weakness against potential bargain opportunities.
F5 (FFIV) trades at $479.27, up 2.7% on the day and near its 52-week high, with a bullish technical trend and strong support at $457. The company reported robust earnings, beating estimates for three consecutive quarters, with Q3 2026 EPS expected at $4.26. Revenue growth accelerated to $3.09B in 2025, and net income margin improved to 22.42%. Recent news highlights F5's leadership in WAAP platforms and AI security innovations, reinforcing its competitive edge.
The outlook for FFIV is positive, driven by earnings momentum and strategic positioning in AI security. However, the stock's elevated valuation multiples (P/E of 36.78) pose a risk if growth slows. Analyst consensus is mixed with a $416.60 price target below the current price, suggesting caution despite bullish technicals. Key risks include competitive pressures and execution challenges in integrating new technologies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
